SilvrSTAT® Antibacterial Wound Dressing Gel
SilvrSTAT® is a multivalent, catalytic, nanoparticulate silver wound dressing gel.
• Quick and continuous antibacterial activity allow for efficient wound management
• No known or expected adverse events due to the low 32ppm silver concentration
• Superior bacteria kill times versus ionic silver products currently available
• Visualization of the wound through transparent gel
• Water-based gel with no alcohol and no sulfa component
SilvrSTAT® Antibacterial Wound Dressing Gel is indicated for the management of wounds including pressure ulcers, venous insufficiency ulcers, diabetic ulcers, lacerations, abrasions, skin tears, surgical incision sites, device insertion site wounds, graft sites, donor sites, and first- and second-degree burns.
Intended for external use only.
There are no known or reasonably suspected adverse reactions associated with the use of SilvrSTAT® Antibacterial Wound Dressing Gel.
Store at room temperature.
32ppm molecular silver
Propylene glycol, triethanolamine, carbopol, purified water
|Absorptive dressing format|
|Alginate dressing format|
|Antimicrobial effects up to 3 days|
|Antimicrobial effects up to 7 days|
|Collagen dressing format|
|Composite dressing format|
|Contact layer dressing format|
|Foam dressing format|
|Gauze or non-woven dressing format|
|Hydrogel (amorphous) dressing format||●|
|Hydrogel (impregnated) dressing format|
|Hydrogel (sheet) dressing format|
|Impregnated dressing format|
|Moisture vapor permeable|
|Secondary dressing required||●|
|Sustained release formula||●|
|Wound filler dressing format|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Non/Minimally Exudating Wounds
SilvrSTAT® Antibacterial Wound Dressing Gel should be applied directly to the wound and covered with a conventional dressing.
SilvrSTAT® Antibacterial Wound Dressing Gel may be changed every 24-72 hours, but the frequency will depend upon the type and condition of the wound.
ABL Medical is the developer of patented multivalent, catalytic, nanomolecular silver technology in the biomedical industry.
ABL Medical's silver has consistently demonstrated the ability, without any known toxic side effects, to inhibit a wide range of bacteria, viruses, yeast, and molds.